biosimilar insulin glargine

DRUG3 trials

Sponsors

Life for a Child Program, Diabetes Australia

Conditions

Type 1 DiabetesType 1 Diabetes (T1D)Type I Diabetes

Phase 4

Introducing Biosimilar Insulin Glargine to the Treatment Regimen of Children and Youth with Type 1 Diabetes in Mali

CompletedNCT06624943

Life for a Child Program, Diabetes AustraliaType 1 Diabetes (T1D)

Start: 2022-03-14End: 2023-05-05Updated: 2024-10-03

Evaluating the Impact of Introducing Basaglar, a Long-acting Analog Insulin, on Clinical and Quality of Life Outcomes in Youth with Diabetes in Bangladesh

CompletedNCT06674135

Life for a Child Program, Diabetes AustraliaType I Diabetes

Start: 2022-06-01End: 2023-08-31Updated: 2024-11-07

Impact of Introducing Basaglar Insulin to the Treatment Regimen of Youth With Diabetes in Pakistan

CompletedNCT06717191

Life for a Child Program, Diabetes AustraliaType 1 Diabetes

Start: 2022-06-09End: 2024-08-02Updated: 2025-07-30